"Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate

Sagel U, Krämer A, Mikolajczyk RT (2012)
BMC Infectious Diseases 12(1): 118.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ;
Abstract / Bemerkung
Recent studies from Austria, France and Italy have shown that there is a poor adherence to the screening scheme for maternal Toxoplasma infections in pregnancy demonstrated by the fact that many recommended examinations are missed. This leads to undetected infections and limits our knowledge of incidence of the disease. We discuss the negative consequences of this situation on research on treatment effectiveness and the outcomes of congenital toxoplasmosis. The responsible public health institutions should assume responsibility for appropriate surveillance of the screening programme and take measures to improve screening adherence during pregnancy. Screening should start as early as possible in pregnancy and the latest test should be done at delivery. Screening schedule should allow distinguishing infections from the first, second and third trimester of pregnancy, as the risk of materno-foetal transmission and outcomes in case of foetal infections varies by time.
Erscheinungsjahr
Zeitschriftentitel
BMC Infectious Diseases
Band
12
Zeitschriftennummer
1
Seite
118
ISSN
PUB-ID

Zitieren

Sagel U, Krämer A, Mikolajczyk RT. "Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate. BMC Infectious Diseases. 2012;12(1):118.
Sagel, U., Krämer, A., & Mikolajczyk, R. T. (2012). "Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate. BMC Infectious Diseases, 12(1), 118. doi:10.1186/1471-2334-12-118
Sagel, U., Krämer, A., and Mikolajczyk, R. T. (2012). "Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate. BMC Infectious Diseases 12, 118.
Sagel, U., Krämer, A., & Mikolajczyk, R.T., 2012. "Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate. BMC Infectious Diseases, 12(1), p 118.
U. Sagel, A. Krämer, and R.T. Mikolajczyk, “"Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate”, BMC Infectious Diseases, vol. 12, 2012, pp. 118.
Sagel, U., Krämer, A., Mikolajczyk, R.T.: "Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate. BMC Infectious Diseases. 12, 118 (2012).
Sagel, Ulrich, Krämer, Alexander, and Mikolajczyk, Rafael T. “"Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate”. BMC Infectious Diseases 12.1 (2012): 118.

1 Zitation in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.
Lykins J, Wang K, Wheeler K, Clouser F, Dixon A, El Bissati K, Zhou Y, Lyttle C, Rzhetsky A, McLeod R., Clin Infect Dis 63(4), 2016
PMID: 27353665

28 References

Daten bereitgestellt von Europe PubMed Central.

Toxoplasmosis
AUTHOR UNKNOWN, 2006
The European Toxo Prevention Study Group: Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis
AUTHOR UNKNOWN, 2008
National public health policies and routines programs to prevent congenital Toxoplasmosis [Unpublished report]. Bordeaux (France)
AUTHOR UNKNOWN, 2005
Prevention of Prenatal Toxoplasmosis by Serological Screening of Pregnant Women in Austria
AUTHOR UNKNOWN, 1992
Congenital toxoplasmosis: 10-year follow up.
Mombro M, Perathoner C, Leone A, Nicocia M, Moiraghi Ruggenini A, Zotti C, Lievre MA, Fabris C., Eur. J. Pediatr. 154(8), 1995
PMID: 7588964
Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data.
SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, Thiebaut R, Leproust S, Chene G, Gilbert R., Lancet 369(9556), 2007
PMID: 17223474
Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres.
Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M, Petersen E, Gilbert R; European Multicenter Study on Congenital Toxoplasmosis., Acta Paediatr. 94(12), 2005
PMID: 16421031
Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii
AUTHOR UNKNOWN, 2003
The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.
Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius H, Petersen E., Arch. Dis. Child. 91(8), 2006
PMID: 16861484
Toxoplasmosis during pregnancy and infancy. A new approach for Switzerland.
Boubaker K, Raeber PA, Vaudaux B, Bucher HC, Garweg JG, Hoesli I, Kind C, Hohlfeld P; Swiss Working Group on congenital Toxoplasmosis., Swiss Med Wkly 138(49-50 Suppl 168), 2008
PMID: 19475733
Screening for toxoplasmosis in pregnancy.
Martinelli P, Agangi A, Maruotti GM., Lancet 369(9564), 2007
PMID: 17350446
Treatment for congenital toxoplasmosis: finding out what works.
Gilbert R., Mem. Inst. Oswaldo Cruz 104(2), 2009
PMID: 19430658
Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis.
Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J., Pediatr. Infect. Dis. J. 27(1), 2008
PMID: 18162934
Management of Toxoplasma gondii infection during pregnancy.
Montoya JG, Remington JS., Clin. Infect. Dis. 47(4), 2008
PMID: 18624630
Why prevent, diagnose and treat congenital toxoplasmosis?
McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H., Mem. Inst. Oswaldo Cruz 104(2), 2009
PMID: 19430661
Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study.
Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE; European Multicentre Study on Congenital Toxoplasmosis (EMSCOT), Gilbert RE, Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Romand S, Thulliez P, Wallon M, Peyron F, Petersen E, Schmidt D, Paul M, Prusa A, Hayde M, Pollak A, Bessieres MH, Franck J, Dumon H, Buffolano W, Romano A, Chemla C, Villena I, Ferret N, Marty P, Pelloux H, Fricker-Hidalgo H, Bost-Bru C, Semprini E, Savasi V, Malm G, Evengard B, Gilbert RE, Tan HK, Freeman K, Salt A, Cortina-Borja M, Tan HK, Freeman K, Ades AE., PLoS Med. 7(10), 2010
PMID: 20967235
Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis.
Thiebaut R, Leroy V, Alioum A, Binquet C, Poizat G, Salmi LR, Gras L, Salamon R, Gilbert R, Chene G., Eur. J. Obstet. Gynecol. Reprod. Biol. 124(1), 2005
PMID: 16140453
Incidence of maternal Toxoplasma infections in pregnancy in Upper Austria, 2000-2007.
Sagel U, Kramer A, Mikolajczyk RT., BMC Infect. Dis. 11(), 2011
PMID: 22168604
Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France
AUTHOR UNKNOWN, 2009
Implementation of Screening for Toxoplasma gondii Infection in Pregnancy.
De Paschale M, Agrappi C, Manco MT, Cerulli T, Clerici P., J Clin Med Res 2(3), 2010
PMID: 21629522
Screening for Toxoplasma gondii antibodies in 2,513 consecutive parturient women and evaluation of newborn infants at risk for congenital toxoplasmosis
AUTHOR UNKNOWN, 2009
Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling.
Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R., Lancet 353(9167), 1999
PMID: 10359407
Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis.
Chene G, Thiebaut R., Mem. Inst. Oswaldo Cruz 104(2), 2009
PMID: 19430657
Infection with Toxoplasma gondii during pregnancy [German]
AUTHOR UNKNOWN, 2005

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 22591211
PubMed | Europe PMC

Suchen in

Google Scholar